Early dysregulation of sphingomyelin metabolism in the striatum of Huntington's disease mouse modelsBiochemical and Biophysical Research CommunicationsIF2.22026-03-180PRE
Abnormal expression of sphingolipid-metabolizing enzymes in the heart of spontaneously hypertensive rat modelsBIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDSIF3.32024-01-012PRE
Treatment with THI, an inhibitor of sphingosine-1-phosphate lyase, modulates glycosphingolipid metabolism and results therapeutically effective in models of diseaseMOLECULAR THERAPYIF122023-01-018PRE
THE DEFECTIVE METABOLISM OF POLYSIALIC ACID (POLYSIA) MAY REPRESENT AN EFFECTIVE THERAPEUTIC TARGET IN HD PRE-CLINICAL MODELSJOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRYIF7.52022-09-120PRE
TREATMENT WITH THI, AN INHIBITOR OF SPHINGOSINE-1-PHOSPHATE LYASE (SGPL1), MODULATES GLYCOSPHINGOLIPID METABOLISM AND RESULTS THERAPEUTICALLY EFFECTIVE IN A MOUSE MODEL OF HUNTINGTON'S DISEASEJOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRYIF7.52022-09-120PRE
PASSIVE IMMUNIZATION, WITH THE ANTI-HUNTINGTIN AGGREGATE ANTIBODY EM48, IS BENEFICIAL IN R6/2 MOUSE MODELJOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRYIF7.52022-09-120PRE
Analgesic Activity of Cinnabarinic Acid in Models of Inflammatory and Neuropathic PainFRONTIERS IN MOLECULAR NEUROSCIENCEIF3.82022-06-026OAAI
Perineuronal nets are under the control of type-5 metabotropic glutamate receptors in the developing somatosensory cortexTRANSLATIONAL PSYCHIATRYIF6.22021-02-1810OAAI
mGlu1 Receptors Monopolize the Synaptic Control of Cerebellar Purkinje Cells by Epigenetically Down-Regulating mGlu5 ReceptorsSCIENTIFIC REPORTSIF3.92018-09-066OAAI
Optical control of pain in vivo with a photoactive mGlu5 receptor negative allosteric modulator (vol 6, e23545, 2017)ELIFEIF02018-01-082OA
Optical control of pain in vivo with a photoactive mGlu5 receptornegative allosteric modulatorELIFEIF02017-04-1147OAAI
Type-1, but Not Type-5, Metabotropic Glutamate Receptors are Coupled to Polyphosphoinositide Hydrolysis in the RetinaNEUROCHEMICAL RESEARCHIF3.82015-12-234PREAI
Pharmacological enhancement of mGlu1 metabotropic glutamate receptors causes a prolonged symptomatic benefit in a mouse model of spinocerebellar ataxia type 1MOLECULAR BRAINIF2.92013-11-1958OAAI
Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate ReceptorsMOLECULAR PHARMACOLOGYIF32012-05-0176PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向